Literature DB >> 12011614

Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis.

Ross M G Norman1, Ashok K Malla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12011614     DOI： 10.1097/00005053-200205000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  4 in total

Review 1.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders.

Authors:  Alan I Green
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 2.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

3.  The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.

Authors:  Maju Mathew Koola; Heidi J Wehring; Deanna L Kelly
Journal:  J Dual Diagn       Date:  2012

Review 4.  Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

Authors:  Eduard Parellada; Miquel Bioque
Journal:  CNS Drugs       Date:  2016-08       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.